Pharmacy Medical News about Colorectal Neoplasms

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Visceral fat area is an Independent Predictive Biomarker of Outcome after First-Line Bevacizumab-Based Therapy in Metastatic Colorectal Cancer
Gut, 10/22/09

ghiringhelli F et al. – The authors study provides the first evidence that high VFA independently predicts a poorer outcome in patients given first–line bevacizumab–based treatment for MCC. However, this predictive biomarker needs to be validated in a different data set.

Exclusive Author Commentary
Francois ghiringhelli, 10/22/09

I think that this article strongly support the hypothesis that fat mass is a major factor that determine the clinical activity of antiangiogenic therapies.

<< Previous
FDA Approves Gardasil to Prevent Genital Warts in Males. Agency...

Next >>
Anti-interleukin-5 antibody treatment (mepolizumab) in active...

P73 expression and its clinical significance in colorectal cancer
Colorectal Disease, 10/19/09 Relevance Score: 68%

Surgical management of colorectal liver metastases
Community Oncology, 10/09/09 Relevance Score: 68%

Establishment of a minimally invasive program at a Veterans Affairs Medical Center leads to improved care in colorectal cancer patients
The American Journal of Surgery, 11/03/09 Relevance Score: 67%

The effect of aspirin in the recurrence of colorectal adenomas: a meta-analysis of randomized controlled trials
Colorectal Disease, 10/15/09 Relevance Score: 67%

Aspirin as Colorectal Cancer Adjuvant Therapy
Gastroenterology, 10/05/09 Relevance Score: 67%